Skip to content
Rituximab-reditux

DR. REDDYS LABORATORIES LTD. (INDIA)

Rituximab-reditux


Rituximab is the Drug / Molecule content in "Reditux". Retuximab is produced through recombinant DNA technology. Retuximab is a monoclonal antibody against the protein found on the surface of immune system B cells. It induces cell death through antibody dependent cellular toxicity, complement dependent cytotoxicity, or apoptosis pathway.


Indication

Retuximab is used  for certain types of cancer such as Lymphomas, Leukemia, Transplant Rejection and some autoimmune disorders. Retuximab may be used alone or in combination with other drugs for the treatment of Non-Hodgkin's Lymphoma and rheumatoid arthritis. 

Note

Precaution

  1. Allergic reactions
  2. Severe infection.

Updated On Oct 31, 2019 by Admin

Strength

100 mg, 500 mg

Packing

Vial

Storage

Store under refrigeration between 2°C to 8°C and protect from direct sunlight. Infusion solutions may be stored at 2°C to 8°C for 24 hrs.



Related Products


NATCO PHARMA LIMITED (INDIA)

Bendamustine-bendit

CIPLA LTD.

Daunotec

Bristol & Myer’s Squibb

Sprycel

Roche

Vesanoid


Most Viewed Products


CIPLA LTD. (INDIA)

Abiraterone acetate-xbira

NATCO PHARMA LIMITED (INDIA)

Bendamustine-bendit

CIPLA LTD. (INDIA)

Bicalutamide-cassotide

NATCO PHARMA LIMITED (INDIA)

Bortezomib-bortenat

NATCO PHARMA LIMITED (INDIA)

Erlonat

Biocon Limited

Everolimus-evertor

NATCO PHARMA LIMITED (INDIA)

Exemestane-xtane

NATCO PHARMA LIMITED (INDIA)

Geftinat

NATCO PHARMA LIMITED (INDIA)

Glatiramer acetate-glatimer

NATCO PHARMA LIMITED (INDIA)

Ledipasvir & sofosbuvir-hepcinat lp

NATCO PHARMA LIMITED (INDIA)

Lenalidomide-lenalid

NATCO PHARMA LIMITED (INDIA)

Pomalidomide-pomalid

NATCO PHARMA LIMITED (INDIA)

Sofosbuvir & velpatasvir-velpanat

NATCO PHARMA LIMITED (INDIA)

Sorafenib-sorafenat

CIPLA LTD. (INDIA)

Tenofovir-tenvir

Quick Query

Direct to your Phone